Ouabain-like factor

被引:36
作者
Goto, A
Yamada, K
机构
[1] Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, Tokyo 113, Japan
[2] Sanraku Hosp, Dept Human Dry Dock, Tokyo 101, Japan
关键词
D O I
10.1097/00041552-199803000-00008
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Accumulated evidence has suggested that several sodium pump inhibitors, similar to cardiotonic steroids, are present in the human body. Ouabain-like factor, the most appealing candidate, has been found to be increased with high sodium intake and hypervolaemia, and in essential hypertension, mineralocorticoid hypertension, and pregnancy-induced hypertension. Furthermore, blocking the action of ouabain-like factor with digibind or a novel anti-ouabain agent lowers blood pressure in several models of hypertension. Several important questions remain, however, before it can be concluded that ouabain-like factor is indeed involved in the regulation of sodium homeostasis and blood pressure. (C) 1998 Rapid Science Ltd.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 63 条
[61]   Elevation of ouabainlike compound levels with hypertonic sodium chloride load in rat plasma and tissues [J].
Yamada, K ;
Goto, A ;
Nagoshi, H ;
Terano, Y ;
Omata, M .
HYPERTENSION, 1997, 30 (01) :94-98
[62]   Interaction of exogenous ouabain and chronic mineralocorticoid treatment in the kidney of the conscious sheep [J].
Yates, NA ;
McDougall, JG .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (01) :57-63
[63]   Low concentrations of ouabain increase cytosolic free calcium concentration in rat vascular smooth muscle cells [J].
Zhu, ZM ;
Tepel, M ;
Neusser, M ;
Zidek, W .
CLINICAL SCIENCE, 1996, 90 (01) :9-12